KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test
Introduction to the Test
The KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test is an advanced diagnostic tool designed to detect genetic mutations associated with spastic ataxia type 2. This test plays a crucial role in understanding the genetic basis of neurological disorders, enabling timely and effective interventions.
What the Test Measures
This test utilizes Next-Generation Sequencing (NGS) technology to analyze the KIF1C gene for mutations that may lead to spastic ataxia type 2. By identifying these genetic variations, healthcare providers can better understand the underlying causes of the disorder.
Who Should Consider This Test
Individuals with a family history of spastic ataxia or those exhibiting symptoms such as:
- Progressive loss of coordination
- Muscle weakness
- Difficulty with balance and walking
should consider this test. Risk factors may include a known family history of neurological disorders.
Benefits of Taking the Test
- Early diagnosis of genetic conditions
- Informed family planning and genetic counseling
- Personalized treatment options based on genetic findings
Understanding Your Results
Results from the KIF1C Gene Spastic Ataxia Type 2 test will be interpreted by a qualified geneticist or neurologist. They will provide guidance on the implications of the findings, potential treatment options, and recommendations for family members.
Test Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test | 40,000 | 56,000 |
Booking the Test
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu, and also offer home sample collection services for your convenience. To book the KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test, please call or WhatsApp us at +254746849631. Your health is our priority!
